메뉴 건너뛰기




Volumn 15, Issue 6, 1999, Pages 497-503

The treatment of peptic ulcer disease

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BISMUTH; CYCLOOXYGENASE 2 INHIBITOR; LANSOPRAZOLE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE DERIVATIVE;

EID: 0032709219     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199911000-00007     Document Type: Article
Times cited : (7)

References (59)
  • 1
    • 0031885142 scopus 로고    scopus 로고
    • What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities?
    • Sprung DJ, Apter MN: What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J Clin Gastroenterol 1998, 26:60-63.
    • (1998) J Clin Gastroenterol , vol.26 , pp. 60-63
    • Sprung, D.J.1    Apter, M.N.2
  • 2
    • 0032056298 scopus 로고    scopus 로고
    • Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: Is empirical therapy justified?
    • Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY: Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical therapy justified? Am J Gastroenterol 1998, 93:574-578.
    • (1998) Am J Gastroenterol , vol.93 , pp. 574-578
    • Jyotheeswaran, S.1    Shah, A.N.2    Jin, H.O.3    Potter, G.D.4    Ona, F.V.5    Chey, W.Y.6
  • 3
    • 0032172997 scopus 로고    scopus 로고
    • Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials
    • Laine L, Hopkins RJ, Girardi LS: Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998, 93:1409-1415. These papers focus attention on the fact that both the prevalence of H. pylori infection in peptic ulcer disease and the ulcer recurrence rate after eradication of H. pylori seem to differ in the United States and the rest of the world.
    • (1998) Am J Gastroenterol , vol.93 , pp. 1409-1415
    • Laine, L.1    Hopkins, R.J.2    Girardi, L.S.3
  • 4
    • 0007429598 scopus 로고    scopus 로고
    • Guidelines for the management of Helicobacter pylori infection
    • Howden CW, Hunt RH: Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol 1998, 93:2330-2338.
    • (1998) Am J Gastroenterol , vol.93 , pp. 2330-2338
    • Howden, C.W.1    Hunt, R.H.2
  • 5
    • 0031893267 scopus 로고    scopus 로고
    • A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China)
    • Mitchell HM, Hu P, Chi Y, Chen MH, Li YY, Hazell SL: A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 1998, 114:256-261. This study was designed to investigate ulcer recurrence and H. pylori re-infection rates in a cohort of Chinese patients. DNA fingerprinting was used to distinguish between recrudescence and re-infection.
    • (1998) Gastroenterology , vol.114 , pp. 256-261
    • Mitchell, H.M.1    Hu, P.2    Chi, Y.3    Chen, M.H.4    Li, Y.Y.5    Hazell, S.L.6
  • 8
    • 0032034130 scopus 로고    scopus 로고
    • Peptic ulcers after the Hanshin-Awaji earthquake: Increased incidence of bleeding gastric ulcers
    • Aoyama N, Kinoshita Y, Fujimoto S, Himeno S, Todo A, Kasuga M, et al.: Peptic ulcers after the Hanshin-Awaji earthquake: increased incidence of bleeding gastric ulcers. Am J Gastroenterol 1998, 93:311-316.
    • (1998) Am J Gastroenterol , vol.93 , pp. 311-316
    • Aoyama, N.1    Kinoshita, Y.2    Fujimoto, S.3    Himeno, S.4    Todo, A.5    Kasuga, M.6
  • 10
    • 0031596224 scopus 로고    scopus 로고
    • H2-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: A prospective study
    • Prach AT, Malek M, Tavakoli M, Hopwood D, Senior BW, Murray FE: H2-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study. Aliment Pharmacol Ther 1998, 12;873-880.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 873-880
    • Prach, A.T.1    Malek, M.2    Tavakoli, M.3    Hopwood, D.4    Senior, B.W.5    Murray, F.E.6
  • 11
    • 0031722191 scopus 로고    scopus 로고
    • Follow-up after eradication of Helicobacter pylori: Symptoms and re-infection
    • Fraser AG, Schreuder V, Chua L-E, Moore L: Follow-up after eradication of Helicobacter pylori: symptoms and re-infection. J Gastroenterol Hepatol 1998, 13:555-559.
    • (1998) J Gastroenterol Hepatol , vol.13 , pp. 555-559
    • Fraser, A.G.1    Schreuder, V.2    Chua, L.-E.3    Moore, L.4
  • 12
    • 0032587351 scopus 로고    scopus 로고
    • Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance anti-secretory treatment in the prevention et recurrence of duodenal ulcer: A prospective, long-term follow, up study
    • Wong BCY, Lam SK, Lei KC, Hu WHC, Ching CK, Ho J, et al.: Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance anti-secretory treatment in the prevention et recurrence of duodenal ulcer: a prospective, long-term follow, up study. Aliment Pharmacol Ther 1998, 13:303-309.
    • (1998) Aliment Pharmacol Ther , vol.13 , pp. 303-309
    • Wong, B.C.Y.1    Lam, S.K.2    Lei, K.C.3    Hu, W.H.C.4    Ching, C.K.5    Ho, J.6
  • 13
    • 0032469040 scopus 로고    scopus 로고
    • The impact of Helicobacter pylori eradication on peptic ulcer healing
    • Treiber G, Lambert JR: The impact of Helicobacter pylori eradication on peptic ulcer healing. Am J Gastroenterol 1998, 93:1080-1084.
    • (1998) Am J Gastroenterol , vol.93 , pp. 1080-1084
    • Treiber, G.1    Lambert, J.R.2
  • 14
    • 0001043167 scopus 로고    scopus 로고
    • How do clinicians practicing in the US manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians
    • Breuer T, Goodman KJ, Malaty HM, Sudhop T, Graham DY; How do clinicians practicing in the US manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol 1998, 93:553-561.
    • (1998) Am J Gastroenterol , vol.93 , pp. 553-561
    • Breuer, T.1    Goodman, K.J.2    Malaty, H.M.3    Sudhop, T.4    Graham, D.Y.5
  • 15
    • 0029086475 scopus 로고
    • Helicobacter pylori and upper gastrointestinal disease: A survey of gastroenterologists in the United Kingdom
    • Milne R, Logan RPH, Harwood D, Misiewicz JJ, Forman D: Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom. Gut 1995, 37:314-318.
    • (1995) Gut , vol.37 , pp. 314-318
    • Milne, R.1    Logan, R.P.H.2    Harwood, D.3    Misiewicz, J.J.4    Forman, D.5
  • 16
    • 0032958703 scopus 로고    scopus 로고
    • The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1 week triple therapies
    • Lind T, Megraud F, Unge P, Bayerdorffer E, O'Morain C, Spiller R, et al.: The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1 week triple therapies, Gastroenterology 1999, 116:248-253.
    • (1999) Gastroenterology , vol.116 , pp. 248-253
    • Lind, T.1    Megraud, F.2    Unge, P.3    Bayerdorffer, E.4    O'Morain, C.5    Spiller, R.6
  • 17
    • 0007522959 scopus 로고    scopus 로고
    • The DU MACH study: Eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy
    • Veldhuyzen van Zanten SJO, Bradette M, Farley A, Leddin D, Lind T, Unge P, et al.: The DU MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999, 13:289-295.
    • (1999) Aliment Pharmacol Ther , vol.13 , pp. 289-295
    • Veldhuyzen van Zanten, S.J.O.1    Bradette, M.2    Farley, A.3    Leddin, D.4    Lind, T.5    Unge, P.6
  • 18
    • 0031684834 scopus 로고    scopus 로고
    • Helicobacter pylori eradication and ulcer healing efficacy with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin
    • Louw JA, van Rensburg CJ, Moola S, Kotze D, Marks IN; Helicobacter pylori eradication and ulcer healing efficacy with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. Aliment Pharmacol Ther 1998, 12:881-885.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 881-885
    • Louw, J.A.1    Van Rensburg, C.J.2    Moola, S.3    Kotze, D.4    Marks, I.N.5
  • 19
    • 0031838350 scopus 로고    scopus 로고
    • Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing
    • Louw JA, van Rensburg CJ, Hanslo D, Grundlingh H de K, Girdwood AH, Marks IN: Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing. Aliment Pharmacol Ther 1998, 12:545-550.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 545-550
    • Louw, J.A.1    Van Rensburg, C.J.2    Hanslo, D.3    Grundlingh, H.D.K.4    Girdwood, A.H.5    Marks, I.N.6
  • 20
    • 0031732311 scopus 로고    scopus 로고
    • Antibiotic resistance in Helicobacter pylori: Implications for therapy
    • Graham DY: Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998, 115:1272-1277.
    • (1998) Gastroenterology , vol.115 , pp. 1272-1277
    • Graham, D.Y.1
  • 21
    • 0031763796 scopus 로고    scopus 로고
    • Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori
    • Megraud F: Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998, 115:1278-1282.
    • (1998) Gastroenterology , vol.115 , pp. 1278-1282
    • Megraud, F.1
  • 22
    • 0031899368 scopus 로고    scopus 로고
    • Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication
    • Van der Hulst RWM, van der Ende A, Homan A, Roorda P, Dankert J, Tytgat GNJ: Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut 1998, 42; 166-169.
    • (1998) Gut , vol.42 , pp. 166-169
    • Van der Hulst, R.W.M.1    Van der Ende, A.2    Homan, A.3    Roorda, P.4    Dankert, J.5    Tytgat, G.N.J.6
  • 23
    • 0031953727 scopus 로고    scopus 로고
    • Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NAPPH nitroreductase
    • Goodwin A, Kersulyte D, Sisson G, Veldhuyzen van Zanten SJ, Berg DE, Hoffman PS: Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NAPPH nitroreductase. Mol Microbiol 1998, 28:283-293. This study was the first to identify the genetic basis for metronidazole resistance, If confirmed, this finding will have important clinical implications.
    • (1998) Mol Microbiol , vol.28 , pp. 283-293
    • Goodwin, A.1    Kersulyte, D.2    Sisson, G.3    Veldhuyzen van Zanten, S.J.4    Berg, D.E.5    Hoffman, P.S.6
  • 24
    • 0006359518 scopus 로고    scopus 로고
    • Kusters JG: Stable Amoxycillin resistance in Helicobacter pylori
    • Van Zwet AA, Vandenbrouke-Grauls CMJE, Thijs JC, van der Wouden EJ, Gerrits MM, Kusters JG: Stable Amoxycillin resistance in Helicobacter pylori, Lancet 1998, 352:1595. This paper presents important documentation of stable amoxicillin resistance in a patient who had received numerous courses of antibiotics.
    • (1998) Lancet , vol.352 , pp. 1595
    • Van Zwet, A.A.1    Vandenbrouke-Grauls, C.M.J.E.2    Thijs, J.C.3    Van der Wouden, E.J.4    Gerrits, M.M.5
  • 25
    • 0009538872 scopus 로고    scopus 로고
    • Aspirin without ulcers
    • Gorman C: Aspirin without ulcers. Time 1998, July:58.
    • (1998) Time , vol.JULY , pp. 58
    • Gorman, C.1
  • 26
    • 0033031331 scopus 로고    scopus 로고
    • COX-2 inhibitors
    • Hawkey CJ: COX-2 inhibitors. Lancet 1999, 353:307-314.
    • (1999) Lancet , vol.353 , pp. 307-314
    • Hawkey, C.J.1
  • 27
    • 0031777185 scopus 로고    scopus 로고
    • Cyclooxygenases 1 and 2
    • Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998, 38:97-120. These papers give comprehensive reviews of the COX-2 theory, its potential applications, and COX-2 development to date.
    • (1998) Annu Rev Pharmacol Toxicol , vol.38 , pp. 97-120
    • Vane, J.R.1    Bakhle, Y.S.2    Botting, R.M.3
  • 28
    • 33748975407 scopus 로고    scopus 로고
    • Analgesic efficacy and plasma levels of a highly selective inhibitor of COX-2 (SC-58635;SC) in patients with post-surgical dental pain
    • Mehlisch DR, Hubbard RC, et al.: Analgesic efficacy and plasma levels of a highly selective inhibitor of COX-2 (SC-58635;SC) in patients with post-surgical dental pain. Clin Pharmacol Ther 1997, 61:195.
    • (1997) Clin Pharmacol Ther , vol.61 , pp. 195
    • Mehlisch, D.R.1    Hubbard, R.C.2
  • 30
    • 0031749806 scopus 로고    scopus 로고
    • Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
    • Wallace JL, Bak A, McKnight W, Asfaha S, Sharkey KA, McNaughton WK: Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 1998, 115;101-109. This paper questions the acceptance of the COX-2 theory, pointing out that COX-1 is required for inflammatory response, at least in the animal model used in this study. It also questions the basis for "selectivity" of the COX-2-selective inhibitors.
    • (1998) Gastroenterology , vol.115 , pp. 101-109
    • Wallace, J.L.1    Bak, A.2    McKnight, W.3    Asfaha, S.4    Sharkey, K.A.5    McNaughton, W.K.6
  • 31
    • 0031052116 scopus 로고    scopus 로고
    • Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
    • Mizuno H, Sakamoto C, Matsuda K, Wade K, Uchida T, Noguchi H, et al.: Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997, 112:387-397.
    • (1997) Gastroenterology , vol.112 , pp. 387-397
    • Mizuno, H.1    Sakamoto, C.2    Matsuda, K.3    Wade, K.4    Uchida, T.5    Noguchi, H.6
  • 32
    • 0032468069 scopus 로고    scopus 로고
    • A guideline for the treatment and prevention of NSAID induced ulcers
    • Lanza FL and the members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology: A guideline for the treatment and prevention of NSAID induced ulcers. Am J Gastroenterol 1998, 93:2037-2046.
    • (1998) Am J Gastroenterol , vol.93 , pp. 2037-2046
    • Lanza, F.L.1
  • 33
    • 0032510315 scopus 로고    scopus 로고
    • A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs
    • for the Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-Associated Ulcer Treatment (ASTRONAUT) Study Group
    • Yeomans ND, Tulassay Z, Juhasz Z, Juhasz L, Racz I, Howard JM, et al., for the Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-Associated Ulcer Treatment (ASTRONAUT) Study Group: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998, 338:719-726.
    • (1998) N Engl J Med , vol.338 , pp. 719-726
    • Yeomans, N.D.1    Tulassay, Z.2    Juhasz, Z.3    Juhasz, L.4    Racz, I.5    Howard, J.M.6
  • 34
    • 0032510378 scopus 로고    scopus 로고
    • Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
    • Hawkey CJ, Karrasch JA, Szcepansky L, Walker DG, Barkun A, Swannel AJ, et al.: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998, 338:727-734. These studies supply experimental evidence favoring the use of omeprazole in the treatment and prevention of NSAID-associated peptic ulceration. Clinical comparisons with ranitidine and misoprostol are made, Hawkey et al. identify a trend for H. pylori-associated ulcers to have a better outcome.
    • (1998) N Engl J Med , vol.338 , pp. 727-734
    • Hawkey, C.J.1    Karrasch, J.A.2    Szcepansky, L.3    Walker, D.G.4    Barkun, A.5    Swannel, A.J.6
  • 35
    • 0030813408 scopus 로고    scopus 로고
    • Randomized trial of eradication of eradication of Helicobacter pylori before non-steroidal anti inflammatory drug therapy to prevent peptic ulcers
    • Chan FKL, Sung JYY, Chung SC, Yung MY, Leung VKS, Lee YT, et al.: Randomized trial of eradication of eradication of Helicobacter pylori before non-steroidal anti inflammatory drug therapy to prevent peptic ulcers. Lancet 1997, 350:975-979.
    • (1997) Lancet , vol.350 , pp. 975-979
    • Chan, F.K.L.1    Sung, J.Y.Y.2    Chung, S.C.3    Yung, M.Y.4    Leung, V.K.S.5    Lee, Y.T.6
  • 36
    • 7844241911 scopus 로고    scopus 로고
    • Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study
    • Chan FKL, Sung JJY, Suen R, Lee YT, Wu JCY, Leung WK, et al.: Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 1998, 12:1201-1205. This single-center study found identical ulcer healing rates in patients with NSAID-associated ulceration who were treated with acid suppression alone or with acid suppression plus eradication therapy.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 1201-1205
    • Chan, F.K.L.1    Sung, J.J.Y.2    Suen, R.3    Lee, Y.T.4    Wu, J.C.Y.5    Leung, W.K.6
  • 37
    • 0032956640 scopus 로고    scopus 로고
    • Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers
    • Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, et al.: Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology 1999, 116:254-258.
    • (1999) Gastroenterology , vol.116 , pp. 254-258
    • Taha, A.S.1    Dahill, S.2    Morran, C.3    Hudson, N.4    Hawkey, C.J.5    Lee, F.D.6
  • 38
    • 0033545555 scopus 로고    scopus 로고
    • Endoscopic retreatment compared with Surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers
    • Lau JY, Sung JJ, Lam YH, Chan AC, Ng EK, Lee DW, et al.: Endoscopic retreatment compared with Surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Eagl J Med 1999, 340:751-756. This potentially important study indicates that repeated endoscopic therapy can be attempted in patients who have rebleeding after initial endoscopic control. It was done in an expert center with dual-treatment methods.
    • (1999) N Eagl J Med , vol.340 , pp. 751-756
    • Lau, J.Y.1    Sung, J.J.2    Lam, Y.H.3    Chan, A.C.4    Ng, E.K.5    Lee, D.W.6
  • 39
    • 0031787092 scopus 로고    scopus 로고
    • Maximal gastric acid secretion in man: A concept that needs precision
    • Waldum HL, Brenna E, Sandvik AK: Maximal gastric acid secretion in man: a concept that needs precision. Scand J Gastroenterol 1998, 33:1009-1015.
    • (1998) Scand J Gastroenterol , vol.33 , pp. 1009-1015
    • Waldum, H.L.1    Brenna, E.2    Sandvik, A.K.3
  • 40
    • 72849170838 scopus 로고
    • The relationship between the acid output of the stomach following "maximal" histamine stimulation and the parietal cell mass
    • Card WI, Marks IN: The relationship between the acid output of the stomach following "maximal" histamine stimulation and the parietal cell mass. Clin Sci 1960, 19:147-163.
    • (1960) Clin Sci , vol.19 , pp. 147-163
    • Card, W.I.1    Marks, I.N.2
  • 41
    • 0032924619 scopus 로고    scopus 로고
    • Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status
    • Gillen D, Wirz AA, Ardill JE, McColl KEL: Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 1999, 116:239-247.
    • (1999) Gastroenterology , vol.116 , pp. 239-247
    • Gillen, D.1    Wirz, A.A.2    Ardill, J.E.3    McColl, K.E.L.4
  • 42
    • 0030468499 scopus 로고    scopus 로고
    • Marked increase in gastric acid secretory capacity after omeprazole treatment
    • Waldum HJ, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK: Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996, 39:649-653.
    • (1996) Gut , vol.39 , pp. 649-653
    • Waldum, H.J.1    Arnestad, J.S.2    Brenna, E.3    Eide, I.4    Syversen, U.5    Sandvik, A.K.6
  • 43
    • 0027015994 scopus 로고
    • Acid secretion 1932-1992: Advances, adaptations and paradoxes
    • Marks IN, Louw JA, Young GO: Acid secretion 1932-1992: advances, adaptations and paradoxes. Scand J Gastroenterol 1992, 27(suppl 193):7-13.
    • (1992) Scand J Gastroenterol , vol.27 , Issue.SUPPL. 193 , pp. 7-13
    • Marks, I.N.1    Louw, J.A.2    Young, G.O.3
  • 44
    • 0032148129 scopus 로고    scopus 로고
    • Effects of Helicobacter pylori on gastritis, pentagastrin stimulated gastric acid secretion, and meal stimulated plasma gastrin release in the absence of peptic ulcer disease
    • Hurlimann S, Dür S, Schwab P, Varga L, Mazzuchelli L, Brand R, Halter F: Effects of Helicobacter pylori on gastritis, pentagastrin stimulated gastric acid secretion, and meal stimulated plasma gastrin release in the absence of peptic ulcer disease. Am J Gastroenterol 1998, 93:1277-1285.
    • (1998) Am J Gastroenterol , vol.93 , pp. 1277-1285
    • Hurlimann, S.1    Dür, S.2    Schwab, P.3    Varga, L.4    Mazzuchelli, L.5    Brand, R.6    Halter, F.7
  • 45
    • 0031719560 scopus 로고    scopus 로고
    • Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication
    • Louw JA, Young GO, Lucke W, Bridger S, Winter TA, Marks IN: Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication. Ital J Gastroenterol Hepatol 1998, 30:363-387.
    • (1998) Ital J Gastroenterol Hepatol , vol.30 , pp. 363-387
    • Louw, J.A.1    Young, G.O.2    Lucke, W.3    Bridger, S.4    Winter, T.A.5    Marks, I.N.6
  • 48
    • 0032081150 scopus 로고    scopus 로고
    • Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors
    • Peghini PL, Katz PO, Bracy NA, Castell DO: Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998, 93:763-767.
    • (1998) Am J Gastroenterol , vol.93 , pp. 763-767
    • Peghini, P.L.1    Katz, P.O.2    Bracy, N.A.3    Castell, D.O.4
  • 50
    • 0033018042 scopus 로고    scopus 로고
    • Structure of the cag pathogenicity island in Japanese Helicobacter pylori isolates
    • Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, et al.: Structure of the cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999, 44:338-341. This study focuses attention on the structure of the cag PAI and suggests that cagA status is a poor marker for the presence of the intact PAI, at least in some populations.
    • (1999) Gut , vol.44 , pp. 338-341
    • Maeda, S.1    Yoshida, H.2    Ikenoue, T.3    Ogura, K.4    Kanai, F.5    Kato, N.6
  • 51
    • 0031738184 scopus 로고    scopus 로고
    • Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island
    • Jenks PJ, Megraud F, Labigne A: Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island. Gut 1998, 43;752-758.
    • (1998) Gut , vol.43 , pp. 752-758
    • Jenks, P.J.1    Megraud, F.2    Labigne, A.3
  • 52
    • 0032949049 scopus 로고    scopus 로고
    • Duodenal Helicobacter pylori infection differs in caga genotype between asymptomatic subjects and patients with duodenal ulcers
    • Hamlet A, Thoreson A-C, Nilsson O, Svennerholm A-M, Olbe L: Duodenal Helicobacter pylori infection differs in caga genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology 1999, 116:259-268.
    • (1999) Gastroenterology , vol.116 , pp. 259-268
    • Hamlet, A.1    Thoreson, A.-C.2    Nilsson, O.3    Svennerholm, A.-M.4    Olbe, L.5
  • 53
    • 0032436331 scopus 로고    scopus 로고
    • A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia
    • Asante MA, Mendall M, Patel P, Ballam L, Northfield TC: A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia. Eur J Gastroenterol Hepatol 1998, 10:983-989.
    • (1998) Eur J Gastroenterol Hepatol , vol.10 , pp. 983-989
    • Asante, M.A.1    Mendall, M.2    Patel, P.3    Ballam, L.4    Northfield, T.C.5
  • 54
    • 0032564695 scopus 로고    scopus 로고
    • Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia
    • McColl KL, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, et al.: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998, 339:1869-1874.
    • (1998) N Engl J Med , vol.339 , pp. 1869-1874
    • McColl, K.L.1    Murray, L.2    El-Omar, E.3    Dickson, A.4    El-Nujumi, A.5    Wirz, A.6
  • 55
    • 0032564656 scopus 로고    scopus 로고
    • Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
    • Blum AL, Talley NJ, O'Morain C, Veldhuyzen van Zanten Z, Labenz J, et al.: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998, 339:1875-1881.
    • (1998) N Engl J Med , vol.339 , pp. 1875-1881
    • Blum, A.L.1    Talley, N.J.2    O'Morain, C.3    Veldhuyzen van Zanten, Z.4    Labenz, J.5
  • 56
    • 0033608720 scopus 로고    scopus 로고
    • on behalf of the Optimal Regimen Cures Helicobacter pylori Induced Dyspepsia (ORCHID) Study Group
    • Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald, on behalf of the Optimal Regimen Cures Helicobacter pylori Induced Dyspepsia (ORCHID) Study Group. BMJ 1999, 18:833-837. These three well-designed studies draw very different conclusions about the role of H. pylori in nonulcer dyspepsia. Differences in design and choice of outcome measures may have influenced the results.
    • (1999) BMJ , vol.18 , pp. 833-837
    • Talley, N.J.1    Janssens, J.2    Lauritsen, K.3    Racz, I.4    Bolling-Sternevald5
  • 57
    • 0031767238 scopus 로고    scopus 로고
    • A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects
    • Williams MP, Sercombe J, Hamilton MI, Pounder RE: A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther 1998, 12:1079-1089.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 1079-1089
    • Williams, M.P.1    Sercombe, J.2    Hamilton, M.I.3    Pounder, R.E.4
  • 58
    • 6844236394 scopus 로고    scopus 로고
    • A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation
    • for the Canadian Critical Care Trials Group
    • Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, et al., for the Canadian Critical Care Trials Group: A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998, 338:791-797.
    • (1998) N Engl J Med , vol.338 , pp. 791-797
    • Cook, D.1    Guyatt, G.2    Marshall, J.3    Leasa, D.4    Fuller, H.5    Hall, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.